Collagen Peptides: What the Human Trials Found

Collagen peptides are the most-studied supplement we cover, which is why they deserve a careful reading rather than a cheerful one. There are real randomized trials here - alongside modest effect sizes, a concentration of authorship around one research institute, and several claims that circulate everywhere and are supported nowhere we could find.

What hydrolyzed collagen is

Collagen peptides and hydrolyzed collagen are the same thing: collagen protein enzymatically broken into short peptide fragments. Labels quote molecular weight ranges with great confidence; we are not repeating a specific range, because no source we checked establishes that any quoted range characterizes what is actually in marketed products.

Collagen types are tissue-specific. Type I predominates in skin, bone, teeth, tendon, ligaments and vasculature; type II is the cartilage collagen; type III is common in skin, muscle and blood vessels (León-López 2019 - León-López A, Morales-Peñaloza A, Martínez-Juárez VM et al. Hydrolyzed Collagen-Sources and Applications. Molecules. 2019;24(22). (opens PubMed in a new tab)).

Does it survive digestion?

Partly, and that “partly” is the whole story.

Digestion should in principle reduce collagen to amino acids like any other protein, making it an expensive source of glycine and proline. What complicates that is that some collagen-derived peptides do appear intact in blood. Sato 2017 - Sato K. The presence of food-derived collagen peptides in human body-structure and biological activity. Food Funct. 2017;8(12):4325-4330. (opens PubMed in a new tab) reports “micromolar levels of food-derived collagen peptides are present in human blood,” against the nanomolar levels typical of most bioactive food peptides. The dipeptide Pro-Hyp (proline-hydroxyproline) is the best-characterized, and the same review reports it “enhances the growth of fibroblasts and synthesis of hyaluronic acid.”

Two qualifications, both from that same review. The fibroblast and hyaluronic acid activity is in vitro - cells in a dish, not skin on a person. And the author says these observations only “partially explain” the benefits of ingesting collagen hydrolysate. That is the author of the mechanistic case telling you the mechanistic case is incomplete.

Skin: the strongest case, and it is getting more tempered

Skin is where the evidence is deepest, and where the trend line is worth watching.

de 2021 - de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461. (opens PubMed in a new tab) pooled 19 double-blind randomized trials covering 1,125 participants (95% female, aged 20–70) and concluded that “ingestion of hydrolyzed collagen for 90 days is effective in reducing skin aging, as it reduces wrinkles and improves skin elasticity and hydration.” That is the sentence most collagen marketing is built on.

Nukaly 2026 - Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306. (opens PubMed in a new tab), also of 19 randomized trials, covering 1,341 participants, is more restrained: only “a modest pooled effect on wrinkle reduction (MD = 0.27, p = 0.04),” while “effects on elasticity and density were inconsistent,” with a call for “larger RCTs with standardized outcomes and histopathologic assessment.”

Read those together. Elasticity was the older literature’s headline finding; the newer synthesis calls it inconsistent. We do not know why - better risk-of-bias handling, newer null trials, different inclusion criteria - and until someone establishes why, that disagreement is the most important fact on this page about skin. The comparison is our editorial framing, not a claim of either paper.

A frequently cited individual trial is Proksch 2014 - Proksch E, Segger D, Degwert J et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. (opens PubMed in a new tab): 69 women aged 35–55, randomized to 2.5 g collagen hydrolysate, 5.0 g, or placebo, 23 per group, for 8 weeks with a 4-week follow-up. Elasticity improved significantly in both collagen groups versus placebo; moisture and transepidermal water loss showed positive trends but did not reach significance overall. Co-authors S. Oesser and M. Schunck are affiliated with CRI, Collagen Research Institute, Kiel.

Joints: two different products that must not be blended

This is the most common error in collagen marketing, and it is not subtle.

Hydrolyzed collagen, around 10 g/day

Clark 2008 - Clark KL, Sebastianelli W, Flechsenhar KR et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin. 2008;24(5):1485-96. (opens PubMed in a new tab) gave 10 g/day of collagen hydrolysate for 24 weeks to athletes with activity-related joint pain. 147 were enrolled; 97 were analyzed - roughly 34% attrition, which is a lot. Physician-assessed joint pain at rest and five patient-reported pain measures improved significantly versus placebo. The effect was more pronounced in the knee-pain subgroup (n=63) - a subgroup analysis, so read it as hypothesis-generating. The lead author was at Penn State; no funding statement is visible on the PubMed record, which is not evidence of independence either way.

The skeptical anchor is Liu 2018 - Liu X, Machado GC, Eyles JP et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167-175. (opens PubMed in a new tab), which assessed 20 supplements across 69 studies. Collagen hydrolysate was among the supplements with “large (effect size >0.80) and clinically important effects for pain reduction at short term.” The same abstract then says the quality of that evidence was “very low,” and that the supplements “had no clinically important effects on pain and function at medium-term and long-term follow-ups.” For context, it also found glucosamine and chondroitin either ineffective or of arguably clinically unimportant effect.

A large effect built on very low quality evidence that disappears past the short term is not a reason to buy. It is a reason for better trials.

UC-II is not hydrolyzed collagen

Undenatured type II collagen (UC-II) is a genuinely different intervention:

• Dose: 40 mg/day, versus about 10 g/day for hydrolysate - roughly 250 times smaller.
• Proposed mechanism: oral tolerance and immune modulation, not supplying raw material. Researchers propose it teaches the immune system not to attack joint cartilage. Whether that operates in humans, rather than being inferred from animal work, is not something we could confirm.

The pivotal trial is Lugo 2016 - Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14. (opens PubMed in a new tab). It randomized 191 subjects with knee osteoarthritis (not healthy volunteers) for 180 days to UC-II 40 mg, glucosamine 1500 mg plus chondroitin 1200 mg, or placebo. Total WOMAC score improved versus placebo (p=0.002) and versus glucosamine/chondroitin (p=0.04).

The trial was manufacturer-sponsored and two of three authors were employed by the ingredient company. But it would be wrong to call it manufacturer-run: its competing-interests disclosure states the study was run and managed independently by a contract research organization, with data collected by site staff and analysis performed by an independent statistician.

Bone: essentially one trial

König 2018 - König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1). (opens PubMed in a new tab) gave 5 g/day of specific collagen peptides or placebo to 131 postmenopausal women for 12 months (102 completers; mean age 64.3). Spine T-score changed by +0.1 ± 0.26 versus −0.03 ± 0.18 for placebo (p=0.030); femoral neck +0.09 ± 0.24 versus −0.01 ± 0.19 (p=0.003).

Those p-values are real. Now look at the numbers in front of them: the absolute changes are small, and the standard deviations are larger than the mean effects. This is one trial, and we could not find an independent, adequately powered replication.

The placebo was maltodextrin - the trial’s methods specify “5 g SCP or placebo (maltodextrin, CARGILL, Paris, France)” (König 2018 - König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1). (opens PubMed in a new tab)). Our own analysis, not a finding of the paper: no trial we found compares collagen against an isonitrogenous protein control, so whether the effect is specific to collagen or attributable to 5 g of any protein is unestablished.

Hair and nails: the thin end

For nails, the study everyone cites is Hexsel 2017 - Hexsel D, Zague V, Schunck M et al. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526. (opens PubMed in a new tab): 25 participants, 2.5 g/day of a specific collagen peptide for 24 weeks. It reported a 12% increase in nail growth rate, 42% fewer broken nails, and 64% global clinical improvement.

The part that rarely makes the marketing: the study was open-label with no control or placebo group. Everyone knew what they were taking and there was nothing to compare against, so placebo response, regression to the mean and the natural variation of nail growth cannot be excluded. The tested ingredient was a bioactive collagen peptide (VERISOL), and a Collagen Research Institute researcher is a co-author.

For hair, we found nothing to cite: our searches did not surface placebo-controlled randomized trials of collagen peptides for hair growth. Be careful how much weight that carries - failing to find results is weaker evidence than finding a null result, and you cannot prove a negative from a literature search. What we can say plainly is that if a product’s main pitch is hair, its main pitch is not evidence.

Bovine, marine, porcine: does the source matter?

We do not know, and the confident answer you have read elsewhere appears to be unsourced.

León-López 2019 - León-López A, Morales-Peñaloza A, Martínez-Juárez VM et al. Hydrolyzed Collagen-Sources and Applications. Molecules. 2019;24(22). (opens PubMed in a new tab) names bovine, porcine, ovine, chicken, duck, rabbit, fish and jellyfish as sources of hydrolyzed collagen. The widely repeated shorthand - marine is type I, bovine is types I and III, chicken is type II - is routinely attributed to that same review, and it is not in the paper. In the full text, “UC-II,” “undenatured” and “sternum” appear zero times, and chicken appears only as a raw material. The review does the tissue-level typing above and names the species. It does not connect the two into a species-to-type map.

That shorthand may well be true. But we could not find a primary source for it, no head-to-head human trial of marine versus bovine surfaced in our searches, and whether sourcing risks (BSE-prion considerations for bovine, allergen risk for marine) differ materially by species is something we have not investigated. Anyone selling you marine collagen on a type argument is selling an argument they have not sourced either.

Does molecular weight actually matter?

Probably less than the label implies, and the honest answer is that nobody has cleanly tested it.

The marketing logic is that smaller peptides absorb better, so lower daltons must mean better results. Two pieces of human evidence bear on it, and neither delivers.

Sugihara 2018 - Sugihara F, Inoue N, Venkateswarathirukumara S. Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study. Sci Rep. 2018;8(1):11403. (opens PubMed in a new tab) randomized 120 subjects (112 completers) with stage II/III pressure ulcers to a hydrolysate of mean molecular weight 5,000 Da, one of 1,200 Da, or placebo. The lower-molecular-weight arm beat placebo on all three endpoints; the higher one on PUSH score only. That sounds like a win for small peptides until you notice two things: the arms were never compared head-to-head, and molecular weight was confounded with dipeptide content - the arms differ in both at once. Molecular weight cannot be isolated as the cause. It is also a wound-healing population, not a cosmetic or joint one.

Iwasaki 2022 - Iwasaki Y, Nakatogawa M, Shimizu A et al. Comparison of gelatin and low-molecular weight gelatin hydrolysate ingestion on hydroxyproline (Hyp), Pro-Hyp and Hyp-Gly concentrations in human blood. Food Chem. 2022;369:130869. (opens PubMed in a new tab), a pharmacokinetic study in nine people, found that low-molecular-weight gelatin hydrolysate significantly raised plasma Pro-Hyp and Hyp-Gly compared with gelatin. But ordinary gelatin hydrolysate did not significantly exceed plain gelatin on Hyp-Gly Cmax or AUC, and the authors concluded that “gelatin is useful as a functional food as effectively as GH.” That is from the people who ran the study, and no collagen brand will put it on a box.

Doses and durations that were actually studied

This is a description of the literature, not a dosing recommendation.

What a skeptical reviewer would say

Hand this literature to a critical reviewer and they would make five points. We think all five land.

1. The pooling may be doing the work. Meta-analyses combine heterogeneous proprietary “specific collagen peptides” across brands, doses, sources and molecular weights. Whether that is one coherent intervention, or whether the pooling manufactures apparent consistency, is unanswered.
2. The control is wrong. Maltodextrin is not a protein. Without an isonitrogenous control, a trial cannot distinguish “collagen works” from “5 g of protein works.”
3. The mechanism stops at the bloodstream. Peptides in plasma, fibroblast effects in a dish, and an author saying his own findings only “partially explain” the results - that is a mechanism sketch, not a mechanism.
4. The best joint result is very low quality by the meta-analysts’ own grading, and it vanishes past the short term.
5. The author list repeats. Which brings us to the next section.

The funding and authorship pattern

This is descriptive. We are not alleging bias or misconduct, and none of it means the findings are wrong.

Steffen Oesser, affiliated with “CRI, Collagen Research Institute GmbH” (Kiel, Germany), is a co-author on the flagship skin trial (Proksch 2014 - Proksch E, Segger D, Degwert J et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. (opens PubMed in a new tab)), the flagship nail study (Hexsel 2017 - Hexsel D, Zague V, Schunck M et al. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526. (opens PubMed in a new tab)), and the flagship bone trial (König 2018 - König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1). (opens PubMed in a new tab)) - all three pillars of the consumer case. The affiliation is verifiable on the bone trial’s author affiliations. M. Schunck, also CRI-affiliated, appears on both the skin trial and the nail study.

Three studies underwriting three different product claims share authors from one institute whose subject is collagen. Weigh that however you like - we would rather you knew.

How to choose

Given the above, the sensible criteria are unglamorous.

• Decide what you are buying it for. Skin has the most support, and it is modest. Everything else is thinner.
• Match the studied dose to the studied outcome. 2.5–5 g/day for skin; ~10 g/day is what joint trials used. If you want UC-II, buy UC-II at 40 mg - not a hydrolysate powder quoting UC-II research.
• Ignore molecular weight marketing until a head-to-head trial isolates it.
• Ignore species-type arguments until someone sources them.
• Give it the studied duration. Meta-analyses emphasize ~90 days for skin. Judging at three weeks tells you nothing.
• Do not pay for an “FDA-registered facility” claim. Third-party testing is worth having, but it addresses purity, not efficacy. Neither is evidence that the product does anything.

We don’t name a specific product here yet — we only list picks that clear our selection criteria and partner standards, and we’d rather show nothing than a name we haven’t verified.

For the full comparison and our selection criteria, see our best collagen peptides guide.

Collagen peptides are among the few supplements with a genuine randomized-trial literature behind them, and a case study in how a modest, contested effect gets marketed as a settled one. Skin is the only domain with a real body of evidence behind it, and the trials there ran 2.5–5 g/day for around 90 days. That is what was studied, and we are not going to inflate it for you.

References

Bibliographic detail is fetched from PubMed, not written by us - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than our judgement.

1. 1.Sato K. The presence of food-derived collagen peptides in human body-structure and biological activity. Food Funct. 2017;8(12):4325-4330.ReviewPMID 29114654
2. 2.León-López A, Morales-Peñaloza A, Martínez-Juárez VM et al. Hydrolyzed Collagen-Sources and Applications. Molecules. 2019;24(22).ReviewPMID 31703345full text
3. 3.de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021;60(12):1449-1461.Meta-analysisPMID 33742704
4. 4.Proksch E, Segger D, Degwert J et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55.Randomised trialPMID 23949208
5. 5.Nukaly HY, Halawani IR, Irtaza HM et al. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2026;13:1618306.Systematic reviewPMID 41924746full text
6. 6.Clark KL, Sebastianelli W, Flechsenhar KR et al. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr Med Res Opin. 2008;24(5):1485-96.Randomised trialPMID 18416885
7. 7.Liu X, Machado GC, Eyles JP et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018;52(3):167-175.Meta-analysisPMID 29018060
8. 8.Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14.Randomised trialPMID 26822714full text
9. 9.König D, Oesser S, Scharla S et al. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018;10(1).Randomised trialPMID 29337906full text
10. 10.Hexsel D, Zague V, Schunck M et al. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526.Clinical trialPMID 28786550
11. 11.Sugihara F, Inoue N, Venkateswarathirukumara S. Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study. Sci Rep. 2018;8(1):11403.Randomised trialPMID 30061579full text
12. 12.Iwasaki Y, Nakatogawa M, Shimizu A et al. Comparison of gelatin and low-molecular weight gelatin hydrolysate ingestion on hydroxyproline (Hyp), Pro-Hyp and Hyp-Gly concentrations in human blood. Food Chem. 2022;369:130869.StudyPMID 34461513
13. 13.FDA - Questions and Answers on Dietary Supplements- US Food and Drug Administrationregulatory

Keep reading

Related guides

All guides →

• best collagen peptidesBest Collagen Peptides: Choosing on the EvidenceStudied doses, third-party testing, molecular-weight marketing and cost per studied dose. The criteria that separate a good collagen from a well-advertised one.8 min readRead guide→
• collagen peptide benefitsCollagen Peptide Benefits: What Human Studies SupportSkin, joints, bone and nails: what collagen trials measured, how large the effects were, and which benefit claims run past the evidence.1 min readRead guide→
• collagen peptides for hairCollagen Peptides for Hair: What the Evidence CoversHair claims for collagen lean on skin and nail research. What has been measured directly, what has not, and how to read before-and-after marketing.1 min readRead guide→
• collagen peptides for jointsCollagen Peptides for Joints: What the Trials FoundJoint comfort and function trials for hydrolyzed collagen and undenatured type II collagen, with the doses, the effect sizes, and who paid for the research.2 min readRead guide→
• collagen peptides for skinCollagen Peptides for Skin: The Trial EvidenceOral collagen for wrinkles and skin aging: what the hydration and elasticity trials measured, how strong the designs are, and how topical collagen differs.1 min readRead guide→
• best peptide serumBest Peptide Serum: How to Choose One on EvidenceWhich peptide, at what concentration, in a formula that makes sense, at what price per mL. The criteria that matter when the marketing all sounds identical.9 min readRead guide→